Share-Based Compensation - Stock Option Activity (Details) (2007 Amended and Restated Long-term Incentive Plan, USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		9 Months Ended			12 Months Ended
	Mar. 31, 2014		Mar. 31, 2014		Mar. 31, 2013	Jun. 30, 2013
Non-qualified Stock Options with Time-based Vesting (NQO) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options	426,365		426,365			557,427
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			1,927
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period			(109,192)
Number of Stock Options, Cancelled/Forfeited			(23,797)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Weighted Average Exercise Price, Beginning balance			$ 12.81
Weighted Average Exercise Price, Granted			$ 18.68
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price			$ 13.20
Weighted Average Exercise Price, Cancelled/Forfeited			$ 15.59
Weighted Average Exercise Price, Ending balance	$ 12.58		$ 12.58			$ 12.81
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Weighted Average Grant Date Fair Value, Beginning balance			$ 5.44
Weighted average fair value of PNQs			$ 9.17		$ 5.56
ShareBased Compensation Arrangement By ShareBased Payment Award,Options, Exercises In Period, Weighted Average Grant Date Fair Value			$ 5.84
Weighted Average Grant Date Fair Value, Cancelled/Forfeited			$ 5.89
Weighted Average Grant Date Fair Value, Ending balance	$ 5.33		$ 5.33			$ 5.44
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value [Roll Forward]
Aggregate Intrinsic Value, Beginning balance	$ 3,153	[1]	$ 3,153	[1]		$ 1,620	[1]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value			0	[1]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Cancellations/Forfeitures in Period, Total Intrinsic Value			0	[1]
Aggregate Intrinsic Value, Ending balance	3,153	[1]	3,153	[1]		1,620	[1]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Weighted Average Remaining Life, Beginning balance	4 years 7 months 6 days					5 years 1 month 6 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Remaining Contractual Term			6 years 7 months 6 days
Weighted Average Remaining Life, Ending balance	4 years 7 months 6 days					5 years 1 month 6 days
Options, Vested and exercisable, Outstanding	214,613		214,613
Options, Vested and exercisable, Weighted Average Exercise Price	$ 14.79		$ 14.79
Options, Vested and exercisable, Weighted Average Grant Date Fair Value			$ 5.72
Options, Vested and exercisable, Weighted Average Remaining Contractual Term			3 years 8 months 12 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	1,172	[1]	1,172	[1]
Options, Vested and expected to vest, Outstanding	413,073		413,073
Options, Vested and expected to vest, Weighted Average Exercise Price	$ 12.63		$ 12.63
Options, Vested and expected to vest, Weighted Average Grant Date Fair Value			$ 5.33
Options, Vested and expected to vest, Exercisable, Weighted Average Remaining Life			4 years 7 months 6 days
Options, Vested and expected to vest, Aggregate Intrinsic Value	3,038		3,038
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value			$ 2,000
Non-qualified Stock Options with Performance-based and Time-based Vesting (PNQ) [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Number of Stock Options, Beginning balance			0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			109,448
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period			0
Number of Stock Options, Cancelled/Forfeited			0
Number of Stock Options, Ending balance	109,448		109,448
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Weighted Average Exercise Price, Beginning balance			$ 0.00
Weighted Average Exercise Price, Granted			$ 21.32
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price			$ 0.00
Weighted Average Exercise Price, Cancelled/Forfeited			$ 0.00
Weighted Average Exercise Price, Ending balance	$ 21.32		$ 21.32
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Weighted Average Grant Date Fair Value, Beginning balance			$ 0.00
Weighted average fair value of PNQs			$ 10.51
ShareBased Compensation Arrangement By ShareBased Payment Award,Options, Exercises In Period, Weighted Average Grant Date Fair Value			$ 0.00
Weighted Average Grant Date Fair Value, Cancelled/Forfeited			$ 0.00
Weighted Average Grant Date Fair Value, Ending balance	$ 10.51		$ 10.51
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value [Roll Forward]
Aggregate Intrinsic Value, Beginning balance	0	[1]	0	[1]		0	[2]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value			0	[2]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Cancellations/Forfeitures in Period, Total Intrinsic Value			0	[1]
Aggregate Intrinsic Value, Ending balance	0	[1]	0	[1]		0	[2]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Weighted Average Remaining Life, Beginning balance			6 years 8 months 12 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Remaining Contractual Term			6 years 8 months 12 days
Weighted Average Remaining Life, Ending balance			6 years 8 months 12 days
Options, Vested and exercisable, Outstanding	0		0
Options, Vested and exercisable, Weighted Average Exercise Price	$ 0.00		$ 0.00
Options, Vested and exercisable, Weighted Average Grant Date Fair Value			$ 0.00
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	0	[1]	0	[1]
Options, Vested and expected to vest, Outstanding	95,600		95,600
Options, Vested and expected to vest, Weighted Average Exercise Price	$ 21.32		$ 21.32
Options, Vested and expected to vest, Weighted Average Grant Date Fair Value			$ 10.51
Options, Vested and expected to vest, Exercisable, Weighted Average Remaining Life			6 years 8 months 12 days
Options, Vested and expected to vest, Aggregate Intrinsic Value	$ 0	[1]	$ 0	[1]

[1] (1) Aggregate intrinsic value represents the total pretax intrinsic value, based on the Company’s closing stock price of $19.70 at March 31, 2014, representing the last trading day of the fiscal quarter ended March 31, 2014, which would have been received by NQO holders had all award holders exercised their NQOs that were in-the-money as of that date.

[2] These amounts represent the estimated portion of the net loss and net prior service cost remaining in AOCI that is expected to be recognized as a component of net periodic benefit cost over the current fiscal year.